Express Pharma - Page 694 of 1139 - Express Pharma

Lonza Capsugel celebrates 25 years of its category-defining joint health solution: UC-II® undenatured type II collagen

Leiutis marks milestone with CDSCO approval for Synthetic Cannabidiol Oral Solution for mild to moderate anxiety disorders

Express Pharma CPHI

Claris Lifesciences posts revenue growth of 25 per cent for quarter ended December 31, 2014

Glenmark’s consolidated revenue increases to Rs 17,013.07 million for Q3 FY 14 – 15

Zydus completes Phase I studies for its oral HIF inhibitor

Sun Pharma posts Q3 results, maintains strong profitability

Signet partners with Galactic

Suven Life Sciences secures product patents from Australia, Canada, Japan and New Zealand

Pfizer’s revenue increases by 16 per cent for third quarter

ABLE-DBT pre budget wish list

Express Pharma (Vol.10, No.8) February 16-28, 2015

TiGenix and Lonza sign agreement